-
Delivering cancer treatment on a nanodisc helps eliminate tumours
europeanpharmaceuticalreview
April 25, 2019
Novel platform for chemo-immunotherapy eliminated colon cancer in 85 percent of treated mice…
-
Nusinersen Promising for Later-Onset Spinal Muscular Atrophy
drugs
April 25, 2019
Nusinersen Promising for Later-Onset Spinal Muscular Atrophy.
-
1998 to 2015 Saw Increase in Outpatient Depression Treatment
drugs
April 25, 2019
From 1998 to 2015, there was an increase in outpatient treatment of depression, according to a study published online April 24 in JAMA Psychiatry.
-
Janssen's Symtuza around 90% effective in achieving undetectable HIV-1 viral loads, when used immediately following diagnosis
pharmafile
April 23, 2019
Janssen's Symtuza around 90% effective in achieving undetectable HIV-1 viral loads, when used immediately following diagnosis
-
Immunotherapy drug could boost hormone treatment for prostate cancer
europeanpharmaceuticalreview
April 22, 2019
Researchers believe the combination with established treatment could improve outcomes in prostate cancer…
-
Prostate cancer treatment reduced from 37 treatments to 5
europeanpharmaceuticalreview
April 22, 2019
A minimally invasive hydrogel technology was administered, and has previously shown to decrease treatment side effects…
-
CDC: Raw Tuna Linked to Salmonella Outbreak in Seven States
drugs
April 18, 2019
CDC: Raw Tuna Linked to Salmonella Outbreak in Seven States.
-
New micro-platform improves understanding of cancer cells
europeanpharmaceuticalreview
April 18, 2019
A new low-cost, cell culture platform technique may provide insight for more effective cancer treatment, according to the researchers who developed it…
-
Intensive BP Lowering May Up Cognitive Decline in Elderly
drugs
April 17, 2019
Intensive BP Lowering May Up Cognitive Decline in Elderly.
-
Late-stage pipeline drugs could compete with only treatment for SMA
europeanpharmaceuticalreview
April 10, 2019
A number of drugs currently in their late stages in the development process could see competition for nusinersen, the only current SMA treatment, rise…